Apnimed, Inc.
APMD
IPO
$24.87
-$3.07-10.99%
NASDAQ
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Net Income | 336.40% | ||||
| Total Depreciation and Amortization | -14.29% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -45.68% | ||||
| Change in Net Operating Assets | -3,280.27% | ||||
| Cash from Operations | 30.37% | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | -- | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | -- | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 117.56% | ||||